Modulation of norepinephrine release by ATP-dependent K+-channel activators and inhibitors in guinea-pig and human isolated right atrium
| Autor: | Hideo Nagashima, F. F. Foldes, Beáta Sperlágh, Ernö Sántha, I Matkó, K. Oe, E.S. Vizi |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Male
Agonist Cromakalim medicine.medical_specialty Adenosine Potassium Channels Sympathetic Nervous System Physiology medicine.drug_class Guinea Pigs In Vitro Techniques Muscarinic Agonists Clonidine Glibenclamide Norepinephrine chemistry.chemical_compound Physiology (medical) Internal medicine Glyburide Muscarinic acetylcholine receptor Adrenergic alpha-2 Receptor Agonists Potassium Channel Blockers medicine Oxotremorine Diazoxide Animals Humans Heart Atria Analysis of Variance Dose-Response Relationship Drug Pinacidil Stimulation Chemical Endocrinology chemistry Adrenergic alpha-1 Receptor Agonists Hydroxy Acids Cardiology and Cardiovascular Medicine Decanoic Acids medicine.drug |
| Zdroj: | Cardiovascular Research. 43:125-134 |
| ISSN: | 0008-6363 |
| DOI: | 10.1016/s0008-6363(99)00052-8 |
| Popis: | The aim of this study was to show, whether ATP sensitive K+ channels (KATP channels), are involved in the modulation of norepinephrine (NE) release from the sympathetic nerves innervating the guinea-pig and human right atrium.The resting and stimulation-evoked release of [3H]norepinephrine ([3H]NE) was measured from the isolated guinea-pig and human right atrium and the effect of activators and inhibitors of ATP sensitive K+ channels was studied.Cromakalim (30-300 microM), a KATP channel-agonist decreased concentration-dependently the stimulation-evoked release of NE from the guinea-pig atrium, an effect, antagonized by glibenclamide, a KATP channel-antagonist (30 microM). Diazoxide (30-300 microM), another activator of the KATP channels reduced the resting release of NE, and also attenuated the evoked release at a single concentration (100 microM), and this latter action was also counteracted by glibenclamide (30 microM). Pinacidil, increased dose-dependently the resting and stimulation-evoked release of NE in a glibenclamide-sensitive manner and reversed the inhibitory effect of cromakalim (100 microM), suggesting that it acts as an antagonist. Glibenclamide (30-300 microM), by itself enhanced the stimulation-evoked release of [3H]NE, and also increased the resting release of NE. On the other hand, 5-hydroxydecanoate, an ischemia-selective inhibitor of cardiac KATP channels did not change NE release. Adenosine, (30-300 microM), an A1-receptor agonist, clonidine (3 microM), an alpha 2-adrenoceptor agonist and oxotremorine, a muscarinic receptor agonist (30 microM) all reduced the evoked release of [3H]NE, but these effects were not modified by glibenclamide (300 microM), indicating that neuronal adenosine (A1), adrenergic (alpha 2) and muscarinic (M3) receptors do not act on KATP channels. In the human right atrium, cromakalim, and diazoxide did not affect significantly the release of [3H]NE. However, glibenclamide (30-300 microM) and pinacidil (30-300 microM) enhanced dose-dependently the evoked-release of NE, and pinacidil also augmented the resting release.Our results indicate that sympathetic nerve endings of the human and guinea-pig atrium are endowed with ATP-sensitive K+ channels. These channels responded to agonists and antagonists under the experimental conditions applied and they could modulate the release of NE thereby affecting the autonomic control of cardiac function under various physiological and pathophysiological conditions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|